SGRY — SURGERY PARTNERS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying SGRY?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 1 tracked investors who changed their SGRY position last quarter, 1 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 57/100 in a Contraction regime).
- +1 tracked investor added or increased positions last quarter (Howard Marks)
- +3 tracked investors reported holding SGRY at their latest filing
- +Macro Health is 57/100 in a Contraction regime — historically acceptable for this sectorsource
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/6/2026.
About SURGERY PARTNERS INC (SGRY)
SURGERY PARTNERS INC (SGRY) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $37M. Across recent filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 1 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in SGRY
How many top investors track SGRY
A small number of top investors own this.
SGRY Ownership Composition
How SURGERY PARTNERS INC is held across tracked investor types, based on reported 13F positions.
- Value & Distressed57.8%
- Multi-Strategy / Quant31.9%
- Macro10.3%
Tracked investors currently reporting SGRY
3 tracked investors have since exited this position — listed separately below.
- Ken GriffinJun 30, 2026Citadel AdvisorsShares475.7KValue$8M% Portfolio0.00%
- Howard MarksJun 30, 2026Oaktree Capital ManagementShares862.6KValue$14.5M% Portfolio0.20%
- Paul Tudor JonesJun 30, 2026Tudor Investment CorpShares153.9KValue$2.6M% Portfolio0.00%
Previously held SGRY
These investors reported SGRY in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Steve Cohen | Point72 Asset Management | 179.9K | $4.3M | Mar 31, 2025 |
| Izzy Englander | Millennium Management | 648.8K | $7.7M | Mar 31, 2026 |
| Ray Dalio | Bridgewater Associates | 18.9K | $450.5K | Jun 30, 2024 |
Recent activity
- New$14.5MAug 14, 2026
- New$450.5KAug 14, 2024
- Sold$0(-100.00%)Nov 13, 2024
Frequently asked questions
- How many institutional investors hold SGRY?
- 3 tracked institutional investors disclosed a position in SGRY (SURGERY PARTNERS INC) in their most recent 13F filing.
- Who is the largest institutional holder of SGRY?
- Steve Cohen, Point72 Asset Management, holds the largest disclosed position in SGRY, valued at $37M.
- Did institutional ownership of SGRY increase or decrease?
- Across recent 13F filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 1 fully exited SGRY.
- Where does this SGRY ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.